The report is titled as ‘Bioprosthetics Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the bioprosthetics market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The bioprosthetics market is expected to grow at a significant rate in the near future.
The global bioprosthetics market in 2020 is estimated for more than US$ 4.4 Bn and expected to reach a value of US$ 9.4 Bn by 2028 with a significant CAGR of 10.0%.
Bioprosthesis is prosthetic heart valves. Prosthetic heart valves are commonly used in the treatment of valvular heart disease. Mechanical valves are more durable than bioprosthetic valves; but, the need for long-term anticoagulant therapy renders them unsuitable for some patient groups.
Prosthetic heart valves are being used since 1960; however, bioprosthetic heart valves are recently launched and are gaining rapid acceptance among surgeons and patients. Bioprosthetic heart valves are made of biologic tissues which are mounted on a fabric-covered plastic frame, called a stent.
Over the past few years, bioprosthesis has seen many technological changes, and many tissues and different animal species aortic valves have been tried with varying results. Today, the most commonly used bioprosthesis is made from porcine aortic valves or from calf pericardium.
Growing prevalence of cardiovascular disorders is the first and foremost factor driving the growth of Bioprosthetics Market. Moreover increasing aging demographics would fuel the growth of Bioprosthetics Market. According to WHO, The absolute number of people aged 60 years and over is expected to increase from 605 million to 2 billion by 2050.
In developed markets such as the U.S. and Europe, patients are preferring bioprosthesis over mechanical valves which are expected to fuel the market for bioprosthesis over the forecast period. However, high cost of procedure and less durability are the factors limiting the growth of global bioprostheis market.
The Bioprosthetics Market is dominated by Medtronic Inc., Abbott, Sorin Group, etc. among others.
The Bioprosthetics Market is segmented on the basis of product type, and region. On the basis of product type, Bioprosthetics Market is segmented as Xenograft or Heterograft, Porcine pericardial valve, Bovine pericardial valve, etc.
The Bioprosthetics Market is expected to increase at steady CAGR over the forecast period owing to the growing aging population and incidence of cardiovascular disorders.
On the basis of region, the Bioprosthetics Market is segmented into six regions namely North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. North America Bioprosthetics Market is expected to be the most dominating market throughout the forecast period due to increasing number of cardiac interventional procedures. Presence of key players in Europe makes it second largest market for bioprosthesis.
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
A research report on the Bioprosthetics Market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
• New product designs and launches
• Current product compliance
• Concerns for use of Bioprosthetics
• Advantage of Bioprosthetics
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
1. Global Bioprosthetics Market Report Overview
1.2. Report Description
2. Global Bioprosthetics Market Overview
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Bioprosthetics Market Snapshot
2.4. Global Bioprosthetics Market Size and Forecast, 2020–2028
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Bioprosthetics Market Dynamics
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Bioprosthetics Market, By Product Type
3.1.1. Annual Growth Rate Comparison, By Product Type
3.1.2. BPS Analysis, By Product Type
3.2. Market Revenue (US$Mn) Forecast, By Product Type
3.2.2. Porcine Pericardial Valve
3.2.3. Bovine Pericardial Valve
3.3. Global Bioprosthetics Market Attractiveness Index, By Product Type
4. Global Bioprosthetics Market, By Region
4.1.1. Annual Growth Rate Comparison, By Region
4.1.2. BPS Analysis, By Region
4.2. Market Revenue (US$Mn) Forecast, By Region
4.2.1. North America
4.2.2. Latin America
4.2.4. Asia Pacific
4.2.5. Middle East and Africa
4.3. Global Bioprosthetics Market Attractiveness Index, By Region
5. North America Bioprosthetics Market Analysis and Forecast, 2020–2028
5.1.1. Annual Growth Rate Comparison, By Country
5.1.2. BPS Analysis, By Country
5.2. Market Revenue (US$Mn) Forecast, By Country
5.2.1. U.S. Bioprosthetics Market
5.2.2. Canada Bioprosthetics Market
5.3. North America Bioprosthetics Market, By Product Type
5.3.2. Porcine Pericardial Valve
5.3.3. Bovine Pericardial Valve
5.4. North America Bioprosthetics Market Attractiveness Index
5.4.1. By Country
5.4.2. By Product Type
6. Latin America Bioprosthetics Market Analysis and Forecast, 2020–2028
6.1.1. Annual Growth Rate Comparison, By Country
6.1.2. BPS Analysis, By Country
6.2. Market (US$Mn) Forecast, By Country
6.2.1. Brazil Bioprosthetics Market
6.2.2. Mexico Bioprosthetics Market
6.2.3. Argentina Bioprosthetics Market
6.2.4. Rest of Latin America Bioprosthetics Market
6.3. Latin America Bioprosthetics Market, By Product Type
6.3.2. Porcine Pericardial Valve
6.3.3. Bovine Pericardial Valve
6.4. Latin America Bioprosthetics Market Attractiveness Index
6.4.1. By Country
6.4.2. By Product Type
7. Europe Bioprosthetics Market Analysis and Forecast, 2020–2028
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market (US$Mn) Forecast, By Country
7.2.1. U.K. Bioprosthetics Market
7.2.2. Germany Bioprosthetics Market
7.2.3. Italy Bioprosthetics Market
7.2.4. France Bioprosthetics Market
7.2.5. Spain Bioprosthetics Market
7.2.6. Russia Bioprosthetics Market
7.2.7. Poland Bioprosthetics Market
7.2.8. BENELUX Bioprosthetics Market
7.2.9. NORDIC Bioprosthetics Market
7.2.10. Rest of Europe Bioprosthetics Market
7.3. Europe Bioprosthetics Market, By Product Type
7.3.2. Porcine Pericardial Valve
7.3.3. Bovine Pericardial Valve
7.4. Europe Bioprosthetics Market Attractiveness Index
7.4.1. By Country
7.4.2. By Product Type
8. Asia Pacific Bioprosthetics Market Analysis and Forecast, 2020–2028
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market (US$Mn) Forecast, By Country
8.2.1. China Bioprosthetics Market
8.2.2. India Bioprosthetics Market
8.2.3. Japan Bioprosthetics Market
8.2.4. Australia and New Zealand Bioprosthetics Market
8.2.5. South Korea Bioprosthetics Market
8.2.6. ASEAN Bioprosthetics Market
8.2.7. Rest of Asia Pacific Bioprosthetics Market
8.3. Asia Pacific Bioprosthetics Market, By Product Type
8.3.2. Porcine Pericardial Valve
8.3.3. Bovine Pericardial Valve
8.4. Asia Pacific Bioprosthetics Market Attractiveness Index
8.4.1. By Country
8.4.2. By Product Type
9. Middle East Bioprosthetics Market, By Region
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) Forecast, By Country
9.2.1. GCC Countries Bioprosthetics Market
9.2.2. Israel Bioprosthetics Market
9.2.3. Oman Bioprosthetics Market
9.2.4. Rest of Middle East Bioprosthetics Market
9.3. Middle East Bioprosthetics Market, By Product Type
9.3.2. Porcine Pericardial Valve
9.3.3. Bovine Pericardial Valve
9.4. Middle East Bioprosthetics Market Attractiveness Index
9.4.1. By Country
9.4.2. By Product Type
10. Africa Bioprosthetics Market, By Region
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) Forecast, By Country
10.2.1. South Africa Bioprosthetics Market
10.2.2. Egypt Bioprosthetics Market
10.2.3. North Africa Bioprosthetics Market
10.2.4. Rest of Africa Bioprosthetics Market
10.3. Africa Bioprosthetics Market, By Product Type
10.3.2. Porcine Pericardial Valve
10.3.3. Bovine Pericardial Valve
10.4. Africa Bioprosthetics Market Attractiveness Index
10.4.1. By Country
10.4.2. By Product Type
11.1. Market Strategy
12. Competitive Landscape
12.1. Competition Dashboard
12.2. List and Company Overview of Global Key Players
12.3. Company Profiles
12.3.1. LeMaitre Vascular, Inc.
188.8.131.52. Company Overview
184.108.40.206. Financial Overview
220.127.116.11. Product Portfolio
18.104.22.168. Key Developments
22.214.171.124. Business Strategies
12.3.2. Braile Biomedica, Inc.
12.3.3. Labcor Laboratorios Ltd.
12.3.4. Maquet Metinge Group
12.3.5. Medtronic Plc.
12.3.6. Aortech International Plc
12.3.7. CryoLife, Inc.
12.3.8. Sorin Group
12.3.9. Humacyte, Inc.
12.3.10. Ethicon, Inc.
12.3.11. LifeCell International
12.3.12. Organogenesis, Inc.
12.3.13. St. Jude Medical, Inc.
12.3.14. Edwards Lifesciences Corporation
12.3.15. JenaValve Technology GmbH